皮质醇作为抑郁症心理治疗反应预测因素的系统综述与荟萃分析
该系统综述与荟萃分析检索Cochrane Library、EMBASE、MEDLINE和PsycINFO数据库,纳入8篇符合标准的文章,评估治疗前皮质醇对抑郁症患者心理治疗反应预测作用。结果显示,心理治疗前皮质醇水平越高,治疗结束时抑郁症状越重和/或症状改善越小。提示HPA轴功能升高的抑郁症患者对心理治疗反应较差。
要点
- 治疗前皮质醇水平越高,抑郁症患者心理治疗结束时症状越重、改善越小。
- HPA轴功能升高的抑郁症患者可能对心理治疗反应较差。
- 皮质醇或可作为抑郁症心理治疗反应的预测指标。
核心结论
- 抑郁症患者心理治疗前皮质醇水平越高,治疗结束时症状越重和/或症状变化越小。
- HPA轴功能升高的抑郁症患者对心理治疗反应较差。
研究设计与样本
- 系统综述与荟萃分析,检索Cochrane Library、EMBASE、MEDLINE和PsycINFO数据库。
- 纳入标准为任何抑郁障碍患者接受心理治疗,且具有治疗前皮质醇和治疗后症状测量。
- 共8篇文章符合选择标准。
主要发现
- 心理治疗前皮质醇水平越高,治疗结束时抑郁症状越重和/或症状变化越小。
临床怎么用
- 对抑郁症患者心理治疗前可考虑评估皮质醇水平,以识别可能反应较差者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many patients with depressive disorders demonstrate resistance to psychological therapy. A frequent finding is hypothalamic-pituitary-adrenal (HPA) axis alterations. As cortisol is known to modulate cognitive processes, those patients may be less likely to profit from psychological therapy. AIMS: To conduct a systematic review and meta-analysis on cortisol as a predictor of psychological therapy response. METHOD: The Cochrane Library, EMBASE, MEDLINE and PsycINFO databases were searched. Records were included if they looked at patients with any depressive disorder engaging in psychological therapy, with a pre-treatment cortisol and a post-treatment symptom measure. RESULTS: Eight articles satisfied our selection criteria. The higher the cortisol levels before starting psychological therapy, the more symptoms patients with depression experienced at the end of treatment and/or the smaller their symptom change. CONCLUSIONS: Our findings suggest that patients with depression with elevated HPA functioning are less responsive to psychological therapy.
引用
- Fischer S, Strawbridge R, Vives AH, et al. Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis. Br J Psychiatry. 2016. PMID: 27908897. doi:10.1192/bjp.bp.115.180653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。